Herpes simplex viruses (HSV) are ubiquitous agents which cause a variety of diseases ranging in severity from mild to severe, and in certain cases, they may became lifethreatening, especially in immunocompromised patients. After primary infection, HSV will persist in the host for the latter's entire lifetime, and HSV infection is thus considered as lifelong infection. Nucleoside analogues such as acyclovir (ACV), penciclovir etc., are the only officially approved drugs for the therapy of HSV infection.
effective in treatment of primary or recurrent HSV infection. However, the widespread use of nucleoside-based drugs has lead to the emergence of HSV strain resistant to those related drugs, especially among immunocompromised patients. According to the previous surveys, the incidence of ACV-resistant strain among immunocompromised patients is around 5% and reaches 14% among bone marrow transplant recipients. [3] [4] [5] The high prevalence of ACV-resistant HSV among these populations suggests that new medication is needed.
Adenoviruses (ADV) are other ubiquitous agents. They are associated with a wide range of illnesses, including ocular, respiratory, gastrointestinal and urinary infections. ADV infection is usually mild and always heals without the need of any special therapy. However, severe ADV infection has been reported in immunocompromised patients, including patients with leukemia, 6 ) AIDS, 7) or organ transplantation. 8) Furthermore, ADV cause pneumonia have been reported to have considerable mortality rate especially in children of age below 2 years old. 9, 10) 5-Iodo-2Ј-deoxyuridine (IDU), ganciclovir, cidafovir and several cysteine protease inhibitors are reported to inhibit ADV infection, and some of them have been used for ADV infection. [11] [12] [13] [14] These agents, however, are either too toxic for use or not approved by governmental agencies for the therapy of ADV infection. In addition, the development of resistance of ADV to related drugs has also been reported in literature. 15) Thus, new and more effective antiviral agents for future therapy in ADV infection are desired.
In our continuous efforts to search for novel antiviral agents from traditional medicinal plants, twelve traditionally used medicinal plants in Taiwan were extracted with hot water (HW) and then investigated for their in vitro anti-HSV and anti-ADV activities. This is the first report on the anti-HSV and ADV activities of the HW extract of the related twelve medicinal plants. Preparation of the Extracts Hot water (HW) extract of the medicinal plants was prepared according to the procedures as described previously by Chang and Yeung with minor modifications. 16) Briefly, different parts of the medicinal plants were boiled with 1000 ml of distilled water for 1 h. The aqueous was collected and the residual was extracted again with another 1000 ml of distilled water. The resulting aqueous extracts were collected, combined, filtered by gauze, concentrated under reduced pressure and then lyophilized to dry. Acyclovir (ACV) and 2Ј,3Ј-dideoxycytidine (ddC) were purchased from Sigma Chemical Co. (U.S.A.). The HW extracts were dissolved in sterile distilled water whereas ACV and ddC were suspended in DMSO.
MATERIALS AND METHODS

Plant Materials
In Vitro
Cell and Viruses The human skin basal cell carcinoma cell line (BCC-1/KMC), established in our laboratory, 17) was used as target cells for virus infection. It was derived from undifferentiated carcinoma cells and grown as adherent cells in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 100 units/ml penicillin G, 100 mg/ml streptomycin and 0.25 mg/ml amphotericin B. In the antiviral assay, the medium was supplemented with 2% FCS and the above mentioned antibiotics. All cell culture reagents and media were purchased from Gibco BRL (Grand Island, New York).
HSV-1 KOS strain was obtained from the American Type Culture Collection (ATCC), Rockville, U.S.A., and HSV-2 196 strain was provided by Professor W. T. Liu (School of Medical Technology, National Yang-Ming Medical University, Taipei, Taiwan). ADV-3, ADV-8 and ADV-11 were provided by Dr. K. H. Lin (Hospital of Kaohsiung Medical University, Kaohsiung, Taiwan). All viruses were prepared and quantitated on BCC-1/KMC cells and stored in small aliquots at Ϫ70°C until use.
Titration of Viruses BCC-1/KMC cells were seeded in 96-well culture plates at a density of 10 4 cells/well and then incubated at 37°C in a humidified atmosphere containing 5% CO 2 for 24 h. A serial dilution of virus stock was prepared, and cells were infected with the dilution of virus. After an additional 72 h of incubation, the cytopathic effect was recorded. The 50% tissue culture infective dose (TCID 50 ) per ml was calculated as described previously by Reed and Muench.
18)
Antiviral Assay Using XTT Method The antiviral activity of HW extracts was evaluated by the XTT method as previously described. 19, 20) BCC-1/KMC cells, treated by trypsin, were seeded in 96-well culture plates with a volume of 70 ml/well and a concentration of 10 5 cells/ml. After 24 h incubation, 20 ml of 25, 20, 120, 20 and 120 TCID 50 of HSV-1, HSV-2, ADV-3, ADV-8 and ADV-11 was added, and the infected cells were incubated for another 2 h. Ten microliter of tested compound at different concentrations was then added to culture wells in triplicate. The final maximum concentration for DMSO in culture medium was 0.1%. For every experiment, a parallel virus control was performed to ensure the viral infectivity remained during the experiment. After further incubation at 37°C with 5% CO 2 for 72 h, the mixture of 0.1 ml PMS (N-methyl dibenzopyrazine methyl sulfate) and 5 mg/5 ml XTT (sodium 3Ј-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy-6-nitro) benzene sulfonic acid hydrate) were added to each well with a volume of 50 ml. The trays were reincubated for an additional 2 h to allow the production of formazan. Optical densities were then determined with the EIA reader (Multiskan EX, Labsystems) at a test wavelength of 450 nm and a reference wavelength of 690 nm.
Viral inhibition rate was calculated as [(ODtvϪODcv)/ (ODcdϪODcv)]ϫ100%. ODtv, ODcv and ODcd indicate the absorbance of the test compounds with virus infected cells, the absorbance of the virus control and the absorbance of the cell control, respectively. The 50% effectiveness concentration (EC 50 ) was defined as the concentration that achieved 50% cyto-protection against virus infection.
Cell Cytotoxic Effect
The cell cytotoxic effect of tested compounds toward BCC-1/KMC cells was evaluated with XTT-based method. It was performed according to the procedures as described above with no virus added. Cell cytotoxic effect of each tested compound was calculated by the following formula: Percent of cell cytotoxic effectϭ[1Ϫ (ODt/ODs)]ϫ100%. ODt and ODs indicate the absorbance of the test substances and the solvent control, respectively. The 50% cell cytotoxic concentration (CC 50 ) of tested compounds was calculated according to Chiang et al. 19) Statistical Analysis Data were calculated as meanϮ standard error for three separate experiments. The selectivity index (SI) was calculated as the ratio of CC 50 to EC 50 . The Student's unpaired t-test was used to calculate p values of difference of means between control and the tested samples on the inhibition of HSV or ADV replication. Difference of sample between tested viruses with a p value less than 0.05 was considered statistically significant.
RESULTS
Antiviral Activity of Twelve Commonly Used Medicinal Plants in Taiwan
Results showed that hot water (HW) extract of twelve commonly used medicinal plants in Taiwan exhibited in vitro anti-HSV and anti-ADV activities at different magnitudes of potency (Table 1) . ACV and ddC were used as a reference compound for anti-HSV and anti-ADV assays, respectively.
The EC 50 for twelve tested HW extracts against HSV-1 infection was in the range of 67-484 mg/ml. B. gracilis and S. japonica showed potent anti-HSV-1 activity with EC 50 of 80.7Ϯ1.5 and 67.5Ϯ2.6 mg/ml, respectively. The anti-HSV-1 activity of A. squamulosa was at moderate potency with EC 50 of 168.5Ϯ10.4 mg/ml. Other nine HW extracts were either mild or little at activity to suppress HSV-1 infection.
When tested for anti-HSV-2 activity, S. japonica showed smallest EC 50 value. The EC 50 of S. japonica was 92.1Ϯ3.8 mg/ml. Beside S. japonica, only two HW extracts had an EC 50 smaller than 200 mg/ml. There were three HW extracts which had EC 50 values in the range of 200-400 mg/ml, and five HW extracts with EC 50 values higher than 500 mg/ml.
For anti-ADV-3 activity, there were B. gracilis and S. japonica that had EC 50 value smaller than 100 mg/ml. The EC 50 value of B. gracilis and S. japonica was 44.1Ϯ19.5 and 72.9Ϯ12.9 mg/ml, respectively. A. princeps, B. pilosa, C. chinense and J. sambac had EC 50 value between 100-150 mg/ml. D. cordata and P. grandiflora had an EC 50 higher than 500 mg/ml.
Our results revealed that four HW extracts possessed EC 50 smaller than 100 mg/ml when tested for anti-ADV-8 activity. These four HW extracts were A. squamulosa, A. princeps, B. gracilis and S. japonica with EC 50 of 96.7Ϯ8.7, 38.6Ϯ8.4, 44.7Ϯ3.2 and 24.6Ϯ8.2 mg/ml, respectively. B. rubra and R. rugosa had an EC 50 between 100-200 mg/ml. There were three HW extracts that had EC 50 higher than 500 mg/ml.
Besides ADV-3 and ADV-8, the extracts were also tested for anti-ADV-11 activity. B. gracilis was the most potent extracts with an EC 50 of 89.8Ϯ3.8 mg/ml. Three HW extracts possessed an EC 50 between 100-200 mg/ml, four HW extracts between 200-300 mg/ml, two HW extracts between 300-400 mg/ml, and two HW extracts higher than 450 mg/ml. Taiwan Table 2 shows the cell cytotoxic effect of HW extracts of the twelve medicinal plants. Overall, all HW extracts showed CC 50 higher than their EC 50 . These observations indicated that the antiviral activity of HW extracts was not a result of their cytotoxic effect toward cells. The CC 50 values ranged from 720 to 4860 mg/ml.
Cell Cytotoxic Effect and Selectivity Index of Twelve Commonly Used Medicinal Plants in
With the EC 50 and CC 50 data, the selectivity index (SI) was calculated by dividing CC 50 by EC 50 . The SI for the anti-HSV-1 assay was in the range of 1.6-37.6, and 1.8-15.6 for the anti-HSV-2 assay. For anti-ADV-3, ADV-8 and ADV-11 assays, the SI ranged from 2.4 to 68.7, 5.6 to 67.8 and 2.5 to 91.1, respectively.
DISCUSSION
Medicinal plants have been traditionally used for different kind of ailments including infectious diseases. Some of them are reported to exhibit antiviral activity in literature. [21] [22] [23] According to the Cragg's report, approximately 60% of antitumor and anti-infective agents that are commercially available or in the late stages of clinical trials today are of natural product origin. 24) There is therefore no doubt that traditional medicinal plants can serve as a potential resource in the development of new antiviral agents in the future. Since current chemotherapy agents for ADV and HSV infections are either insufficient in quantity or limited in efficiency, there is thus a need to search for new and more effective antiviral agents for future therapy in ADV and HSV infections.
In this study, XTT assay was used for the evaluation of antiviral activity because it is a simple, fast and efficient 1602 Vol. 26, No. 11 method. 25, 26) This assay not only has lesser steps than the traditional plaque assay, but also avoids the irradiation of radioisotopes. Furthermore, the data of examination were read and printed with an EIA reader. It is therefore very sensitive and convenient for massive screening on antiviral activity of medicinal plants.
Among the twelve tested medicinal plants, two of them were found to exhibit a broad spectrum of antiviral activity. These two medicinal plants were B. gracilis and S. japonica. B. gracilis is also named as Anredra cordifolia (Tenore) van Steen. In Taiwan, it is traditionally used as the treatment for gastric pain, cough, diabetes and liver diseases. 27) Previous studies demonstrated that B. gracilis showed weak antimutagenic activity. 28) S. japonica, also known as Japanese serissa, is commonly used for the treatment of carbuncle on the back and edema in Taiwan. 29) Our studies revealed that B. gracilis and S. japonica suppressed four (HSV-1, ADV-3, ADV-8, ADV-11) and five (HSV-1, HSV-2, ADV-3, ADV-8, ADV-11) virus infections, respectively.
The HW extracts of these two medicinal plants also showed noteworthy SI value. Although they are less effective than the reference compounds, ACV for HSV assay and ddC for ADV assay, their SI, however, were valuable. For example, the SI of B. gracilis against all tested ADV infections was generally higher than that of ddC. Also S. japonica had higher SI against ADV-8 infection than that of ddC.
Another interesting observation was the anti-ADV-8 activity of A. squamulosa and A. princeps. HW extracts of these two medicinal plants had smaller EC 50 against ADV-8 infection than that of two other tested ADV infections, ADV-3 and ADV-11 (pϽ0.05). Human ADV have at least 51 serotypes and are divided into six groups (A-F) on the basis of their physical, chemical, and biological properties. 30) Their DNA is Ͼ90% in homology for the members of a given group but is Ͻ20% in homology between the members of different groups. In classification, ADV-3 and ADV-11 are group B ADV, and ADV-8 is group D ADV. The stronger potency of A. squamulosa and A. princeps against ADV-8 infection than against ADV-3 or ADV-11 infection suggested that these two medicinal plants target some unique properties of ADV-8. Further investigations are necessary to clarify the underlying mechanism action of A. squamulosa and A. princeps against ADV-8 infection.
Our previous study showed that hot water extract of Biden pilosa LINN. var. minor (Blume) SHERFF (Compositae) (HWBPLS) possessed in vitro anti-HSV-1 and anti-HSV-2 activities. 31) In this study, we showed that hot water extract of Biden pilosa LINN. (Compositae) (HWBPL) exhibited anti-HSV and anti-ADV activities. By comparing the EC 50 values for both medicinal plants, it was revealed that HWBPL was more effective against HSV replication than that of HWB-PLS. The EC 50 values of HWPBL against HSV-1 and HSV-2 infection were 279.4 (pϽ0.05, compared with HWPBLS) and 221.8 mg/ml ( pϽ0.05, compared with HWPBLS), whereas those of HWPBLS were 655.4 and 960.0 mg/ml, respectively. Also, the SI values of HWBPL were smaller than those of HWPBLS (The SI values of HWBPL against HSV-1 and HSV-2 were 9.7 and 12.2, and of HWPBLS were Ͼ1.53 and Ͼ1.04, respectively). Since the same virus strain, host cell, procedures of antiviral activity assessment and extraction method of medicinal plants, etc. were used for both studies, we therefore suggest that the continuous investigation on anti-HSV activity of HWBPL is more promising and encouraging than that of HWPBLS. The studies regarding the different anti-HSV activity between HWBPL and HWPBLS will also be conducted in the near future.
In summary, the HW extract of twelve traditionally used medicinal plants in Taiwan was concluded to exhibit anti-HSV and anti-ADV activities at different magnitudes of potency. Among the tested medicinal plants, the anti-HSV and anti-ADV activities of B. gracilis and S. japonica, and the anti-ADV activity of A. squamulosa and A. princeps are encouraged for further investigation.
